24 results
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
1 Mar 24
Entry into a Material Definitive Agreement
8:50am
-Corruption. Seller has not, in violation in any respect of applicable anti-corruption or anti-bribery laws, offered, given, promised or authorized
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
of 1977, as amended, or any other applicable anti-bribery, anti-corruption, anti-money laundering, record keeping and internal control Laws, including … , in connection with alleged or possible violations of any Law that prohibits bribery, corruption, fraud, or other improper payments.
Section 4.14 Regulatory
S-3ASR
EX-1.2
jfi7f8f
3 Jan 22
Automatic shelf registration
8:51am
10-Q
rxjb0m
17 May 21
Quarterly report
4:26pm
10-K
t23b0e 2bkv4lyarg9
29 Mar 21
Annual report
4:26pm
424B4
ds22l
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
7iqmtgn8bjkk 4e8anp
30 Nov 20
IPO registration (amended)
6:05am
S-1/A
EX-1.1
72m5cs
30 Nov 20
IPO registration (amended)
6:05am